Indication
Bronchitol is indicated for the treatment of cystic fibrosis (CF) in adults aged 18 years and above as an add-on therapy to best standard of care.
In other countries
The same active substances on other registers, the same brand first.
National listings
The national registers that list this EU medicine.
- Bronchitol 40 MG Polvo Para Inhalacion, Capsulas DurasSpain · 40 mg · polvo para inhalación (cápsula dura) · Pharmaxis Europe LimitedSame brand
- BronchitolCroatiaSame brand
- Bronchitol 40 mg inhalatiepoeder, harde capsulesNetherlands · Inhalatiepoeder in harde capsule · Pharmaxis Europe LimitedSame brand
- BronchitolUnited States · 40MG · powder · Pharmaxis EuropeSame brand